Blood Transfusion News and Research

RSS

Blood transfusion is the process of transferring blood or blood-based products from one person into the circulatory system of another. Blood transfusions can be life-saving in some situations, such as massive blood loss due to trauma, or can be used to replace blood lost during surgery.

Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer

Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer.

3 Oct 2007

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors -- including the former medical director of the Canadian Red Cross and two government officials -- of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).

2 Oct 2007

Fetal cell "transplant" could be a hidden link between childbirth and reduced risk of breast cancer

Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer.

2 Oct 2007

Majority of Europeans with hepatitis C remain undiagnosed

A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.

1 Oct 2007

FDA licenses 15 new blood typing tests

The U.S. Food and Drug Administration today licensed 15 new blood typing tests that were previously unavailable in the United States.

17 Sep 2007

FDA committees recommend continued U.S. marketing for Trasylol

The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.

13 Sep 2007

FDA approves cobas TaqScreen WNV test for West Nile virus

The U.S. Food and Drug Administration has announced approval of a second test for the detection of West Nile virus (WNV) in blood and organs.

29 Aug 2007

FDA approves new Roche direct detection of West Nile Virus in donated human blood

Roche Diagnostics announced that the US Food & Drug Administration (FDA) has approved its biologics license application for the company's test for direct detection of West Nile Virus in donated human blood and plasma.

From Roche Sequencing and Life Science 29 Aug 2007

High-dose chemotherapy and a stem cell transplant cures testicular cancer

Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.

26 Jul 2007

Mathematical model identifies genes which fight viruses

Joint research by Dr. Leonid Brodsky, of the Institute of Evolution of the University of Haifa, and Dr. Milton Taylor, of Indiana University, led to the discovery of a mathematical method which can identify which genes in our bodies conduct the battle against the various viruses that attack us.

18 Jul 2007

New method to detect vCJD infection

Scientists have made significant advances towards the development of a technique that could be used to confirm whether someone is infected with variant CJD.

9 Jul 2007

Researchers step toward a Creutzfeldt-Jakob disease test

Researchers have shown that a recently developed laboratory method to amplify prions (Protein Misfolding Cyclic Amplification) can be applied to variant CJD (Creutzfeldt-Jakob Disease).

4 Jul 2007

Elimination of Chagas disease by 2010

A new effort to eliminate Chagas disease by 2010 will be launched tomorrow at a WHO meeting of disease experts and partners.

3 Jul 2007

Safe blood for safe motherhood

On the occasion of World Blood Donor Day, the theme of which this year is "Safe blood for safe motherhood", WHO is launching a new initiative to improve the availability and use of safe blood to save the lives of women during and after childbirth.

19 Jun 2007

A cure for Hepatitis C using existing treatments

Researchers in the United States say they have discovered that people infected with hepatitis C can be cured with existing treatments.

23 May 2007

New guidelines for blood conservation during cardiac procedures

A team of medical experts led by a Virginia Commonwealth University anesthesiologist and a thoracic surgeon from the University of Kentucky has established a set of clinical guidelines to help physicians decrease the need for blood transfusions in high-risk patients during cardiac operations.

17 May 2007

Fluorescent nanoparticles open up new possibilities for cellular imaging

Scientists from the University of Twente, the Netherlands, have successfully exploited the optical properties of fluorescent nanoparticles to broaden the scope of single-cell microscopy.

9 May 2007

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.

17 Apr 2007

Report on radical prostatectomy for octogenarians

There is no defined recommendation for when to stop prostate cancer (CaP) screening, except when the life expectancy decreases to less than 10 years.

16 Apr 2007

FDA approves Soliris (eculizumab), first treatment for paroxysmal nocturnal hemoglobinuria

The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.

19 Mar 2007